Aragon Pharmaceuticals, Inc.;Sloan-Kettering Institute for Cancer Research
发明人:
DILHAS, Anna,OUERFELLI, Ouathek,SMITH, Nicholas D.,HERBERT, Mark R.
申请号:
LT18157435
公开号:
LT3348553T
申请日:
2013.06.04
申请国别(地区):
LT
年份:
2020
代理人:
摘要:
Described herein are crystalline forms of the androgen receptor modulated 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3,4]oct-5-yl]-2-fluoro-N-methylbenzamide, pharmaceutically acceptable salts, solvates, as well as pharmaceutical compositions thereof, and the same for use in treatment or prevention of diseases or conditions associated with androgen receptor activity.